Madrigal Pharmaceuticals Inc (MDGL)
Equity Ratio
42.08%
Quarterly · Period ending:
MDGL Equity Ratio
Latest reported42.08%period ending
Latest reported42.08%period ending
MDGL Quarterly Equity Ratio (85.31% → 42.08%)
Latest values, visible window
High-resolution chart · PNG
MDGL equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 42.0782% | |
| 44.2795% | |
| 47.8481% | |
| 45.9267% | |
| 68.5435% | |
| 71.3041% | |
| 72.3804% | |
| 72.4104% | |
| 77.9349% | |
| 78.608% | |
| 63.2792% | |
| 9.3497% | |
| 34.2213% | |
| 45.1606% | |
| 54.4413% | |
| 6.7258% | |
| 38.6036% | |
| 65.4553% | |
| 71.7468% | |
| 77.0867% | |
| 82.5269% | |
| 84.1224% | |
| 83.6147% | |
| 85.3032% | |
| 88.2921% | |
| 93.6854% | |
| 94.2335% | |
| 96.514% | |
| 97.2679% | |
| 97.695% | |
| 98.2605% | |
| 98.6432% | |
| 98.8941% | |
| 96.5696% | |
| 94.7721% | |
| 86.435% | |
| 90.5446% | |
| 85.3656% | |
| 88.3523% | |
| 90.567% | |
| 92.5141% | |
| 83.6908% | |
| 73.916% | |
| 66.3305% | |
| 67.9365% | |
| 58.1167% | |
| 64.6993% | |
| 67.7104% | |
| 63.8211% | |
| 46.5103% | |
| 51.5646% | |
| 25.7876% | |
| 47.9357% | |
| 60.4098% | |
| 72.8676% | |
| 55.8728% | |
| 43.389% | |
| 56.4329% | |
| 34.9069% | |
| 45.6319% | |
| 55.5264% | |
| 30.52% | |
| 43.4257% | |
| 45.3707% | |
| 67.5909% | |
| 69.3758% | |
| 50.9323% | |
| 53.5701% | |
| -129.8705% | |
| -88.4192% | |
| -60.4516% | |
| -38.1319% | |
| -11.7284% | |
| 10.057% | |
| 20.2986% | |
| 69.7517% | |
| 73.2696% | |
| 81.6191% | |
| -3.1886% | |
| 15.605% | |
| 73.6933% | |
| 85.3088% |